- <![CDATA[FDA Approves T-DXd for Early-Stage HER2+ Breast Cancer]]><![CDATA[The FDA approved trastuzumab deruxtecan for the adjuvant and neoadjuvant treatment of select early-stage HER2-positive breast cancer.]]>onclive · 2mo ago↗ source
- <![CDATA[Dr Garzotto on Aglatimagene Besadenovec Plus Valacyclovir and EBRT in Localized Prostate Cancer]]><![CDATA[Mark Garzotto, MD, discusses efficacy data with aglatimagene besadenovec plus valacyclovir and EBRT in localized prostate cancer.]]>onclive · 2mo ago↗ source
- <![CDATA[Dr Cirstea on Sequencing Considerations in R/R Multiple Myeloma]]><![CDATA[Diana Cirstea, MD, discusses sequencing considerations in relapsed/refractory multiple myeloma in the era of T-cell–redirecting therapies.]]>onclive